SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-007479
Filing Date
2024-01-29
Accepted
2024-01-29 17:29:36
Documents
17
Period of Report
2023-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192407-8k_fresh2group.htm   iXBRL 8-K 38983
2 SHARE PURCHASE AGREEMENT DATED DECEMBER 10, 2023 ea192407ex10-1_fresh2group.htm EX-10.1 183161
3 PRESS RELEASE DATED JANUARY 4, 2024 ea192407ex99-1_fresh2group.htm EX-99.1 5708
  Complete submission text file 0001213900-24-007479.txt   476876

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fres-20231210.xsd EX-101.SCH 3863
5 XBRL DEFINITION FILE fres-20231210_def.xml EX-101.DEF 26768
6 XBRL LABEL FILE fres-20231210_lab.xml EX-101.LAB 37014
7 XBRL PRESENTATION FILE fres-20231210_pre.xml EX-101.PRE 25392
19 EXTRACTED XBRL INSTANCE DOCUMENT ea192407-8k_fresh2group_htm.xml XML 5470
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24575051
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)